WINQ Eyelid Serum: The Clinically-Proven Solution for Digital Eye Strain Subtitle
Antimicrobial
Ocular inflammation is consistently found in patients with dry eye and has become a reliable biomarker for both symptomatic and asymptomatic sufferers. An important part of the management of this inflammation is to reduce the bacterial load on the lid-margin.1,2,3
The WINQ Eyelid Serum is a breakthrough, clinically-tested over-the-counter solution for patients suffering from digital eye strain and reduced blinking—a pervasive problem across nearly every demographic in modern practice.
A Solution to Screen-Induced Dry Eye:
This unique serum targets the root cause of screen-induced discomfort by restoring the natural blink mechanism, directly supporting tear film health, and offering rapid relief in a single, dual-action product.
Targeting the Cause of Screen Fatigue
The WINQ Eyelid Serum is an innovative, evidence-based therapy. It uses gentle cooling plant extracts to target the TRPM8 cold receptors in the periocular area, which naturally activates and increases the patient’s subconscious blink rate. This action helps to constantly refresh the tear film, reduce evaporation, and alleviate eye fatigue.
Key Features of WINQ
Clinically Proven
A Randomised Controlled Trial (RCT) showed a significant 27% increase in blink rate and a 50% reduction in partial blink rate post-application.
Dual-Action Therapy
Combines essential eye health benefits (blink activation, hydration) with premium skincare ingredients, increasing patient appeal
Key Ingredients
Contains Hyaluronic Acid (HA) for superior hydration and lubrication, alongside Caffeine and Niacinamide to visibly reduce puffiness and dark circles.
Interested in using WINQ Eyelid Serum in your practice?
Contact us to find out more about TearRestore WINQ Eyelid Serum and to order.
Read the news on Positive Impact
Dry Eye January: Empower your patients to take control of their eye health. Learn how to educate and engage your patients about the importance of early diagnosis and treatment for dry eye.
Positive Impact, in partnership with Visioneering Technologies, Inc. (VTI), has won The Contact Lens Award at the prestigious Optician Awards 2024 for its NaturalVue® Enhanced Multifocal 1 Day contact lens.
Join Nick Atkins in this CPD webinar as he explores effective heat delivery options for managing MGD. Gain insights into both in-practice and at-home solutions to enhance your practice’s MGD management strategies.
